Market cap
₹5,311 Cr
Recently Viewed
Clear AllNSE: ENTERO | BSE: 544122
₹1,216.40
₹25.00
(2.10%)
As on 30-Apr-2026IST
Market cap
₹5,311 Cr
Revenue (TTM)
₹6,020 Cr
P/E Ratio
47.1
P/B Ratio
3
Div. Yield
0 %
Quality Score
0/0
Growth Score
0/0
Valuation Score
0/0
Momentum Score
0/0
Today’s Range
52 Week Range
Liquidity
Net Profit (TTM)
₹113 Cr
ROE
6.4 %
ROCE
9.2 %
Industry P/E
45.99
EV/EBITDA
22.1
Debt to Equity
0.2
Book Value
₹413.7
EPS
₹27.2
Face value
10
Shares outstanding
43,510,937
CFO
₹-262.74 Cr
EBITDA
₹393.38 Cr
Net Profit
₹91.34 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Entero Health
| 18.5 | -1.8 | 10.0 | -9.5 | -- | -- | -- |
|
BSE Healthcare
| 2.7 | 6.8 | 7.9 | 5.7 | 24.7 | 13.8 | 11.1 |
|
Company
|
2025
|
|---|---|
|
Entero Health
| -28.5 |
|
BSE Small Cap
| -6.6 |
|
BSE Healthcare
| -3.3 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Entero Health
|
1,216.4 | 5,311.2 | 6,020.3 | 132.1 | 3.2 | 6.8 | 47.1 | 3.0 |
| 35.9 | 15.8 | 25.3 | 0.1 | 0.4 | 2.5 | 138.6 | 3.3 | |
| 28.1 | 35.1 | 16.0 | -4.4 | -58.4 | -3.7 | -- | 0.3 | |
| 21.9 | 31.1 | 49.7 | 4.1 | -- | 29.1 | 7.5 | 1.5 | |
| 41.9 | 26.3 | 4.6 | 0.4 | 1.7 | 4 | 67.3 | 2.6 | |
| 45.4 | 24.8 | 294.6 | 2.1 | 0.9 | 163.8 | 12.1 | 9.8 | |
| 330.5 | 290.3 | 58.3 | 8.6 | -- | 37.9 | 33.7 | 4.9 | |
| 109.3 | 213.4 | 106.8 | 4.8 | -- | 14.9 | 44.5 | 5.7 | |
| 2.1 | 8.3 | 110.0 | -0.2 | 0.0 | -3.5 | -- | 1.7 | |
| 0.3 | 34.6 | 386.8 | 35.4 | 11.1 | 29.9 | 1 | 0.2 |
IPO: Entero Healthcare Solutions
4 min read•By Satyajit Sen
Entero Healthcare Solutions Limited engages in the distribution and marketing of pharmaceutical, surgical products and other allied services in India. The company is involved in the distribution of generic formulations, active pharmaceutical... ingredients, surgical consumables, rehabilitation products and devices, over the counter medical products, nutraceuticals, biosimilars, and biologics. It also offers nebulizers, personal protective, hygiene and surgical consumable products, homecare medical devices, gloves and mobility equipment, digital thermometers. In addition, the company offers healthcare products, including pharmaceutical and nutraceutical products, vaccines, medical devices such as orthopaedic implants and coronary stents, and hospital consumables such as examination and surgical gloves, syringes, needles and sutures to hospitals, retail pharmacies, healthcare product manufacturers, and healthcare clinics. Entero Healthcare Solutions Limited was incorporated in 2018 and is based in Mumbai, India. Read more
Incorporated
2018
Chairman
Sujesh Vasudevan
Managing Director
Prabhat Agrawal
Headquarters
Faridabad, Haryana
Website
Looking for more details about Entero Healthcare Solutions Ltd’s IPO? Explore our IPO Details page.
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
The share price of Entero Healthcare Solutions Ltd is ₹1,216.40 (NSE) and ₹1,220.65 (BSE) as of 30-Apr-2026 IST. Entero Healthcare Solutions Ltd has given a return of -9.52% in the last 1 years.
The P/E ratio of Entero Healthcare Solutions Ltd is 47.12 times as on 30-Apr-2026, a 2 premium to its peers’ median range of 45.99 times.
The P/B ratio of Entero Healthcare Solutions Ltd is 2.95 times as on 30-Apr-2026, a 883 premium to its peers’ median range of 0.30 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
52.15
|
2.88
|
|
2024
|
109.53
|
2.62
|
|
2023
|
0.00
|
0.00
|
|
2022
|
0.00
|
0.00
|
|
2021
|
0.00
|
0.00
|
The 52-week high and low of Entero Healthcare Solutions Ltd are Rs 1,510.80 and Rs 944.00 as of 30-Apr-2026.
Entero Healthcare Solutions Ltd has a market capitalisation of ₹ 5,311 Cr as on 30-Apr-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Entero Healthcare Solutions Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.